This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
T. Rowe Price (TROW) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
T. Rowe (TROW) delivered earnings and revenue surprises of 12.25% and 0.03%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
5 ROE Picks to Beat Market Blues Amid Surging Volatility
by Supriyo Bose
ROE is often used to compare the profitability of a company with other firms in the industry - the higher, the better.
Investment Managers' Earnings Due on Jul 29: RJF, AMP & More
by Radhika Saraogi
Results of investment managers are expected to reflect net inflows and higher assets, backed by support from solid equity markets.
Will Solid Equity Markets Aid T. Rowe Price (TROW) Q2 Earnings?
by Zacks Equity Research
T. Rowe Price's (TROW) Q2 results will likely display the positive impact of strong equity markets.
T. Rowe Price (TROW) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
T. Rowe (TROW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Dismal Fee Income to Impact Fifth Third's (FITB) Q2 Earnings
by Zacks Equity Research
Fifth Third's (FITB) Q2 results are expected to reflect prudent expense control, offset by top-line pressure.
Will Trading Revenues Support E*TRADE's (ETFC) Q2 Earnings?
by Zacks Equity Research
E*TRADE's (ETFC) Q2 earnings likely to reflect an improved trading performance, partly negated by the depressing impact of a lower net interest income.
Navient (NAVI) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Lower interest rates and an increase in expenses are expected to have hurt Navient's (NAVI) Q2 earnings.
Will Low Fee Income Hurt Northern Trust's (NTRS) Q2 Earnings?
by Zacks Equity Research
Northern Trust (NTRS) Q2 results expected to reflect decline in fees and the unfavorable impact of lower rates on its net interest income.
Will T. Rowe (TROW) Gain on Rising Earnings Estimates?
by Zacks Equity Research
T. Rowe (TROW) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Lower Rates, Fee Income to Mar Comerica's (CMA) Q2 Earnings
by Zacks Equity Research
Soft interest income due to low rates and weak fee income might have hurt Comerica's (CMA) Q2 earnings amid the coronavirus crisis.
Investment Management Industry Outlook Bright on Asset Inflows
by Nikita Kataruka
Asset inflows amid the coronavirus outbreak-induced economic uncertainty are expected to aid growth in assets under management, which will likely support asset managers' top line to some extent.
Low Rates to Mar Regions (RF) Q2 Earnings Amid Coronavirus Crisis
by Zacks Equity Research
Regions (RF) Q2 results expected to reflect soft loan growth and the unfavorable impact of lower rates on its net interest income.
Can T. Rowe (TROW) Run Higher on Strong Earnings Estimate Revisions?
by Zacks Equity Research
T. Rowe (TROW) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.
5 ROE Picks Amid Rising Sino-American & Coronavirus Tensions
by Supriyo Bose
ROE enables investors to identify stocks that diligently deploy cash for higher returns.
Zacks.com featured highlights include: T. Rowe Price, The Clorox Company, Lockheed Martin, Xilinx and The Sherwin-Williams Company
by Zacks Equity Research
Zacks.com featured highlights include: T. Rowe Price, The Clorox Company, Lockheed Martin, Xilinx and The Sherwin-Williams Company
Will T. Rowe (TROW) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
T. Rowe (TROW) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
7 GARP Stocks to Scoop Up for Maximum Returns
by Zacks Equity Research
If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.
Deutsche Bank CEO Sees Slowdown in Trading Activities in 2H20
by Zacks Equity Research
Deutsche Bank's (DB) chief executive officer believes that the coronavirus outbreak-led volatility is expected to subside in the latter half of 2020, thus leading to a decline in trading activities.
People's United Launches Service to Monitor Digital Identity
by Zacks Equity Research
Amid the changing preference to digital modes of banking, People's United's (PBCT) new platform would help monitor and reduce scams.
Goldman to Resolve 1MDB Legal Case Post Guilty Plea Decision
by Zacks Equity Research
The case related to the multibillion-dollar 1Malaysia Development Bhd (1MDB) scandal which involved Goldman (GS) might be resolved soon post-decision of pleading guilty by the bank.
Citi to Boost Commercial Banking in Nordics Amid Coronavirus Woes
by Zacks Equity Research
Citigroup (C) to expand commercial banking operations in the Nordics to grab opportunities and cater to clients' needs amid the coronavirus pandemic.
Zacks.com featured highlights include: BWX Technologies, Lowes Companies, State Street, The Clorox Company and T. Rowe Price
by Zacks Equity Research
Zacks.com featured highlights include: BWX Technologies, Lowes Companies, State Street, The Clorox Company and T. Rowe Price
4 ROE Stocks to Buy as Coronavirus Resurgence Spooks Markets
by Supriyo Bose
ROE is often used to compare the profitability of a company with other firms in the industry ??? the higher, the better.
5 GARP Stocks for a Winning Portfolio
by Zacks Equity Research
Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.